Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein
- 4 July 2015
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 160 (9) , 2293-2300
Abstract
Middle East respiratory syndrome (MERS) coronavirus (Co-V) contains a single spike (S) protein, which binds to a receptor molecule, dipeptidyl peptidase 4 (DPP4; also known as CD26), and serves as a neutralizing antigen. Pseudotyped viruses are useful for measuring neutralization titers against highly infectious viruses as well as for studying their mechanism of entry. In this study, we constructed a series of cytoplasmic deletion mutants of MERS-CoV S and compared the efficiency with which they formed pseudotypes with vesicular stomatitis virus. A pseudotype bearing an S protein with the C-terminal 16 amino acids deleted (MERSpv-St16) reached a maximum titer that was approximately tenfold higher than that of a pseudotype bearing a non-truncated full-length S protein. Using MERSpv-St16, we demonstrated the inability of rat DPP4 to serve as a functional receptor for MERS-CoV, suggesting that rats are not susceptible to MERS-CoV infection. This study provides novel information that enhances our understanding of the host range of MERS-CoV.Keywords
Funding Information
- Ministry of Health, Labor, and Welfare of Japan (H25 Shinko-Ippan-008)
- JSPS KAKENHI (26450418)
This publication has 27 references indexed in Scilit:
- Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4Journal of Virology, 2014
- Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014Eurosurveillance, 2014
- Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus InfectionJournal of Virology, 2014
- Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome CoronavirusJournal of Virology, 2014
- Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyThe Lancet Infectious Diseases, 2013
- Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013Eurosurveillance, 2013
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26Nature, 2013
- Pneumonia from Human Coronavirus in a Macaque ModelNew England Journal of Medicine, 2013
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaNew England Journal of Medicine, 2012
- Use of Vesicular Stomatitis Virus Pseudotypes Bearing Hantaan or Seoul Virus Envelope Proteins in a Rapid and Safe Neutralization TestClinical and Vaccine Immunology, 2003